Quanterix Corp (NAS:QTRX)
$ 11.06 -0.01 (-0.09%) Market Cap: 426.08 Mil Enterprise Value: 169.82 Mil PE Ratio: 0 PB Ratio: 1.26 GF Score: 71/100

Quanterix Corp at Needham Healthcare Conference Transcript

Apr 14, 2020 / 03:20PM GMT
Release Date Price: $22.01 (+8.21%)
Joseph Conway
Needham & Company - Analyst

Welcome to the 19th Annual Needham Healthcare Conference. My name is Joseph Conway and I'm pleased to host our next presentation from Quanterix. Joining me today is Chairman and Chief Executive Officer Kevin Hrusovsky, and Chief Financial Officer Amol Chaubal.

In terms of the format for this session, Kevin and Amol are going to provide a business overview with slides followed by a Q&A session for the remainder of the available time. (Operator Instructions). With that I'll hand the floor over to Kevin and Amol.

Kevin Hrusovsky
Quanterix Corp. - President, Chairman & CEO

Thank you very much. This is Kevin Hrusovsky. I will do the presentation and then Amol will join me for questions following it. Please check your regulatory filings before investing in Quanterix. Let us start by just saying we have this disruptive technology that does, in fact, provide the ability to see early and noninvasively disease in blood. And that is a way to really significantly advance the healthcare system.

This

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot